[artículo] 
inPsychiatric Clinics of North America > Año 2003 - Vol. 26 No. 1 (Marzo) . - pp. 141-163

Título :	The new and evolving pharmacotherapy of schizophrenia
Tipo de documento:	texto impreso
Autores:	Robin Emsley, Autor ; Piet Oosthuizen, Autor
Fecha de publicación:	2020
Artículo en la página:	pp. 141-163
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antipsicóticos, Calidad de vida, Esquizofrenia.
Resumen:	Based on the evidence presented here, the following tentative conclusions can be drawn. Atypical antipsychotics (except amisulpride) have shown superiority over placebo in acute schizophrenia. Compared with conventional antipsychotics, they are at least as effective. Generally, analyses employing conservative criteria (e.g., Cochrane reviews) report few efficacy differences between atypical and conventional agents.
Link:	./index.php?lvl=notice_display&id=24826

[artículo] The new and evolving pharmacotherapy of schizophrenia [texto impreso] / Robin Emsley, Autor ; Piet Oosthuizen, Autor . - 2020 . - pp. 141-163.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Psychiatric Clinics of North America > Año 2003 - Vol. 26 No. 1 (Marzo) . - pp. 141-163

Palabras clave:	Antipsicóticos, Calidad de vida, Esquizofrenia.
Resumen:	Based on the evidence presented here, the following tentative conclusions can be drawn. Atypical antipsychotics (except amisulpride) have shown superiority over placebo in acute schizophrenia. Compared with conventional antipsychotics, they are at least as effective. Generally, analyses employing conservative criteria (e.g., Cochrane reviews) report few efficacy differences between atypical and conventional agents.
Link:	./index.php?lvl=notice_display&id=24826